Varex Imaging Corporation (NASDAQ:VREX) saw its stock soar 5.08% in after-hours trading on Tuesday. The surge came after the medical imaging technology company reported better-than-expected financial results for the fourth quarter of fiscal year 2024 and provided an optimistic revenue outlook for the upcoming quarter.
For the quarter ended September 27, 2024, Varex reported non-GAAP earnings per share of $0.19, surpassing analysts' expectations of $0.09. The company's revenue of $205.7 million also exceeded estimates of $199.4 million, despite a 9.5% year-over-year decline. The strong performance was driven by strength in the company's Industrial segment, which helped offset a 12% drop in its Medical segment.
Looking ahead, Varex provided guidance for the first quarter of fiscal 2025, expecting revenue between $195 million and $215 million. The company also projected non-GAAP net earnings per diluted share to range from a loss of $0.05 to a profit of $0.10 for the upcoming quarter.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。